Severe Hypertension
Cardiovascular
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
DS
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Daiichi SankyoCS-3150
Clinical Trials (1)
Total enrollment: 20 patients across 1 trials
Study of CS-3150 in Patients With Severe Hypertension
Start: Jun 2016Est. completion: Feb 201720 patients
Phase 3Completed
Related Jobs in Cardiovascular
Embedded Software and System Test Engineer (H/F)
Cardiawave
Levallois-Perret, France (Hybrid)
Just now
Territory Sales Manager - Iowa / Nebraska
HeartFlow
Cedar Rapids, IA; Des Moines, IA; Omaha, NE; Lincoln, NE
Yesterday
From $150K/yr
Associate Regulatory Affairs Specialist
Medtronic
Mounds View, Minnesota, United States of America
Yesterday
$60K - $90K/yr
Business Development Manager, Post Transplant, Cardio Thoracic
Thermo Fisher Scientific
Remote
Yesterday
Operador Fabricacion Sueros Orales TEMPORAL
Abbott
Mexico - Cuidad de Mexico - Cuidad de Mexico
Yesterday
Director, Medical Affairs
Abbott
Germany - Hesse - Eschborn
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space